Aktuellt
SENASTE
Redeye shares its initial take on Physitrack’s Q3 results, which were generally in line with our modest expectations. Lifecare maintained its growth trajectory, though overall growth—reported at 1% organically—was tempered by weaker performance in the Wellness division. Highlights included stable ARR growth at 12% year over year. Given the continuation of softness in the Wellness division, we expect to make downward adjustments to our estimates and fair value range.
LÄS MER
